The Role of TP53 in Adaptation and Evolution

被引:43
作者
Voskarides, Konstantinos [1 ,2 ]
Giannopoulou, Nefeli [1 ]
机构
[1] Univ Nicosia, Med Sch, Dept Basic & Clin Sci, CY-2414 Nicosia, Cyprus
[2] Univ Nicosia, Sch Vet Med, CY-2414 Nicosia, Cyprus
关键词
oncogene; natural selection; environment; genetics; antagonistic pleiotropy; tumor; fitness; clonal expansion; animal model; phylogenetics; SUBTERRANEAN MOLE-RAT; ARG72PRO POLYMORPHISM; P53; PATHWAY; DNA-DAMAGE; CANCER; EXPRESSION; GENE; MUTATION; MUTANT; MICE;
D O I
10.3390/cells12030512
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The TP53 gene is a major player in cancer formation, and it is considered the most important tumor suppressor gene. The p53 protein acts as a transcription factor, and it is involved in DNA repair, senescence, cell-cycle control, autophagy, and apoptosis. Beyond cancer, there is evidence that TP53 is associated with fertility, aging, and longevity. Additionally, more evidence exists that genetic variants in TP53 are associated with environmental adaptation. Special TP53 amino-acid residues or pathogenic TP53 mutations seem to be adaptive for animals living in hypoxic and cold environments or having been exposed to starvation, respectively. At the somatic level, it has recently been proven that multiple cancer genes, including TP53, are under positive selection in healthy human tissues. It is not clear why these driver mutations do not transform these tissues into cancerous ones. Other studies have shown that elephants have multiple TP53 copies, probably this being the reason for the very low cancer incidence in these large animals. This may explain the famous Peto's paradox. This review discusses in detail the multilevel role of TP53 in adaptation, according to the published evidence. This role is complicated, and it extends from cells to individuals and to populations.
引用
收藏
页数:11
相关论文
共 50 条
  • [31] Tumor Suppressors in Zebrafish: From TP53 to PTEN and Beyond
    den Hertog, Jeroen
    CANCER AND ZEBRAFISH: MECHANISMS, TECHNIQUES, AND MODELS, 2016, 916 : 87 - 101
  • [32] TP53 in Myelodysplastic Syndromes: Recent Biological and Clinical Findings
    Cumbo, Cosimo
    Tota, Giuseppina
    Anelli, Luisa
    Zagaria, Antonella
    Specchia, Giorgina
    Albano, Francesco
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (10)
  • [33] The TP53 gene promoter is not methylated in families suggestive of Li-Fraumeni syndrome with no germline TP53 mutations
    Finkova, Alena
    Vazna, Alzbeta
    Hrachovina, Ondrej
    Bendova, Sarka
    Prochazkova, Kamila
    Sedlacek, Zdenek
    CANCER GENETICS AND CYTOGENETICS, 2009, 193 (01) : 63 - 66
  • [34] Telomere status in chronic lymphocytic leukemia with TP53 disruption
    Guieze, Romain
    Pages, Melanie
    Veronese, Lauren
    Combes, Patricia
    Lemal, Richard
    Gay-Bellile, Mathilde
    Chauvet, Martine
    Callanan, Mary
    Kwiatkowski, Fabrice
    Pereira, Bruno
    Vago, Philippe
    Bay, Jacques-Olivier
    Tournilhac, Olivier
    Tchirkov, Andrei
    ONCOTARGET, 2016, 7 (35) : 56976 - 56985
  • [35] Relationship of TP53 gene with retroelements in urogenital organs carcinogenesis
    Mustafin, R. N.
    ONKOUROLOGIYA, 2022, 18 (01): : 136 - 142
  • [36] Allelic loss at TP53 in metastatic human endometrial carcinomas
    Szewczuk, Wiktor
    Skomra, Danuta
    Cybulski, Marek
    Przadka-Rabaniuk, Dorota
    Filip, Agata
    Jozwik, Maciej
    Olcha, Piotr
    Roessner, Albert
    Semczuk, Andrzej
    CLINICAL & EXPERIMENTAL METASTASIS, 2009, 26 (07) : 789 - 796
  • [37] Mutations of the TP53 gene in adenocarcinoma and squamous cell carcinoma of the cervix: A systematic review
    Tornesello, Maria Lina
    Buonaguro, Luigi
    Buonaguro, Franco M.
    GYNECOLOGIC ONCOLOGY, 2013, 128 (03) : 442 - 448
  • [38] Comprehensive characterization of genes associated with the TP53 signal transduction pathway in various tumors
    Ohnami, Shumpei
    Ohshima, Keiichi
    Nagashima, Takeshi
    Urakami, Kenichi
    Shimoda, Yuji
    Saito, Junko
    Naruoka, Akane
    Hatakeyama, Keiichi
    Mochizuki, Tohru
    Serizawa, Masakuni
    Ohnami, Sumiko
    Kusuhara, Masatoshi
    Yamaguchi, Ken
    MOLECULAR AND CELLULAR BIOCHEMISTRY, 2017, 431 (1-2) : 75 - 85
  • [39] MUT-TP53 2.0: A Novel Versatile Matrix for Statistical Analysis of TP53 Mutations in Human Cancer
    Soussi, Thierry
    Hamroun, Dalil
    Hjortsberg, Linn
    Rubio-Nevado, Jean Michel
    Fournier, Jean Louis
    Beroud, Christophe
    HUMAN MUTATION, 2010, 31 (09) : 1020 - 1025
  • [40] Mutation of the TP53 Gene in Placental Chorangiomatosis
    Luo, Ying
    FETAL AND PEDIATRIC PATHOLOGY, 2023, 42 (03) : 400 - 409